Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179049 · ClinicalTrials.gov registry record
Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
A clinical trial of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation, sponsored by Vanderbilt University.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00179049: Completed study of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation, sponsored by Vanderbilt University.
NCT00179049 is a study of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation that has completed, run by Vanderbilt University. The registered enrollment target is 100 participants, below the 135-participant average among 36 other Graft Vs Host Disease trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00179049, a study of Graft Vs Host Disease and Hematopoietic Stem Cell Transplantation, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2003-04 |
| Est. Completion | 2008-04 |
What the finished NCT00179049 record still lists
NCT00179049 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 135-participant average among 36 other Graft Vs Host Disease trials with a reported enrollment target (26% lower).
The record links to 2 conditions, with Graft Vs Host Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00179049 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00179049 about?
NCT00179049 is a clinical study titled "Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant". The investigators' hypothesis is that the graft-versus-tumor effect can be enhanced while minimizing the complications of graft-versus-host disease.
What is the current status of trial NCT00179049?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2003-04. Estimated completion is 2008-04.
What conditions does trial NCT00179049 study?
This clinical trial studies the following conditions: Graft Vs Host Disease, Hematopoietic Stem Cell Transplantation.
Who is sponsoring clinical trial NCT00179049?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00179049 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Graft Vs Host Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00179049's enrollment target sits among peer trials
100 11th of 36 higher than 25 of 36 other Graft Vs Host Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Graft Vs Host Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
RECRUITING
-
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
RECRUITING · NA
-
IS-free Treg HaploHCT
RECRUITING · Phase 1
-
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
RECRUITING · Phase 2
-
A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
RECRUITING · Phase 1
-
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia